Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-023974

Chief Financial Officer sold 15,000 shares at an average $24.47 ($367,029)

  • Chief Financial Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-04-08 Option exercise +15,000 $4.07 $61,050 16,000 D
Cohen Chad M Chief Financial Officer 2020-04-08 Sale −9,700 $24.14 $234,158 6,300 D
Cohen Chad M Chief Financial Officer 2020-04-08 Sale −5,300 $25.07 $132,871 1,000 D
Derivatives
Cohen Chad M Chief Financial Officer 2020-04-08 Option exercise · Stock Option (Right to Buy) −15,000 30,000 D
Open-market sales · 15,000 sh · avg $24.47 · $367,029
Loading xslF345X03/doc4.xml…